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Abstract
Arrhythmias figure prominently among the complications encountered in the varied and diverse 
population of patients with congenital heart disease, and are the leading cause of morbidity and 
mortality. The incidence generally increases as the patient ages, with multifactorial predisposing 
features that may include congenitally malformed or displaced conduction systems, altered 
hemodynamics, mechanical or hypoxic stress, and residual or postoperative sequelae. The safe 
and effective management of arrhythmias in congenital heart disease requires a thorough 
appreciation for conduction system variants, arrhythmia mechanisms, underlying anatomy, and 
associated physiology. We, therefore, begin this review by presenting the scope of the problem, 
outlining therapeutic options, and summarizing congenital heart disease-related conduction 
system anomalies associated with disorders of the sinus node and AV conduction system. 
Arrhythmias encountered in common forms of congenital heart disease are subsequently 
discussed. In so doing, we touch upon issues related to risk stratification for sudden death, 
implantable cardiac devices, catheter ablation, and adjuvant surgical therapy.                         
Key words:  Congenital heart disease; Atrial arrhythmias; Ventricular arrhythmias; Sudden 
cardiac   death                                                                                              
Scope Of The Problem                                                                                           
Congenital heart disease is the most common form of birth defect, with an estimated 1-2% of 
live newborns afflicted by moderate or severe types [1]. Arrhythmias figure prominently among 
the healthcare issues encountered and pose unique and diverse challenges [2,3]. The incidence of 
arrhythmias generally increases as the patient with congenital heart disease ages. Indeed, by 
adulthood, arrhythmias are the leading cause of morbidity and hospital admissions [4,5], and 
sudden death of presumed arrhythmic etiology is the most common cause of mortality [6,7].
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Arrhythmias may reflect congenitally malformed or displaced conduction systems, altered 
hemodynamics, mechanical and/or hypoxic stress, and/or residual or postoperative sequelae 
[5,8].  The entire gamut of arrhythmia subtypes may occur in patients with congenital heart 
disease, with several forms often coexisting. Bradyarrhythmias may involve disorders of the 
sinus node, atrioventricular  (AV) node, His-Purkinje system,  or intra-atrial propagation.  
Junctional tachyarrhythmias are common, particularly in young post-operative patients [9]. 
Atrial tachyarrhymias are highly prevalent and may be mediated by accessory pathways, dual 
AV nodal reentry, twin AV nodes, macroreentrant circuits, automatic rhythms, or non-automatic 
foci. Atrial fibrillation is increasingly prevalent in the growing and aging population of adults 
with congenital heart disease. Ventricular arrhythmias are thought to be the leading cause of 
sudden death in several subtypes of congenital heart disease.                                     
Therapeutic   options                                                                          
Importantly, arrhythmias may herald a changing hemodynamic profile and should generally 
prompt a detailed work-up. The care of the patient with congenital heart disease and arrhythmias 
may involve pharmacological therapy, catheter ablation, implantable cardiac devices, and 
surgical   interventions.                                                                                    
In the absence of specific evidence-based recommendations, pharmacological therapy is often 
guided by principles established in other forms of heart disease [10,11]. These include 
considerations regarding systemic ventricular dysfunction, sinus node disease, impaired AV 
node conduction, negative inotropic effects, and proarrhythmia. The comparative efficacy of 
antiarrhythmic agents remains poorly studied, with little data regarding dosing and toxicity for 
the   various   age   groups   with   congenital   heart   disease.   Amiodarone-associated   thyroid 
dysfunction is common in adults with congenital heart disease, especially in women and those 
with complex cyanotic heart disease or univentricular hearts with Fontan palliation [12]. There 
is much interest in the new generation of class III antiarrhythmic agents that purport fewer 
multisystemic   side-effects   without   increased   mortality   in   the   setting   of   left   ventricular 
dysfunction. In a multicenter case series, dofetilide appeared to be a viable adjunct to catheter-
based ablation and alternative pharmacological approaches for atrial arrhythmias in adult 
patients with congenital heart disease [10].                                                                               
 
Anatomical   complexities   and   vascular   access   issues   may   complicate   catheter-based 
interventions and implantation of pacemakers or implantable cardioverter-defibrillators (ICD) 
[2,13,14]. Challenges in device therapy include circumventing obstructed vessels, conduits, or 
baffles; minimizing thromboembolic risk in the presence of intracardiac shunts; identifying 
appropriate candidates for cardiac resynchronization therapy and primary prevention ICDs; 
configuring adequate vectors for defibrillation despite small sizes and/or limited vascular access; 
and a high rate of inappropriate shocks and lead complications [2,13,15,16].   Although the 
success rate is modest, some patients may benefit from pacemakers with automated overdrive 
pacing algorithms to terminate atrial tachyarrhythmias [17].                                                
With the advent of three-dimensional electroanatomic mapping and advances in catheter 
technology permitting larger and deeper lesions, transcatheter ablation has emerged as a 
promising alternative for many patients with tachyarrhythmias.  While acute success rates in 
dedicated centers are high, recurrences and the onset of new arrhythmias remain problematic, 
particularly in patients with Fontan palliation.  In certain circumstances, arrhythmia surgery, 
usually performed in conjunction with cardiac surgery for other indications, may complement 
less invasive options.                                                                                                      
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Conduction System Considerations                                                                                   
Sinus node                                                                                                               
Most patients with congenital heart disease have a normally positioned sinus node. Exceptions 
include left juxtaposition of the atrial appendages, situs inversus, and heterotaxy syndromes. In 
left juxtaposition of the atrial appendages, both appendages are on the left side of the arterial 
pedicle [18]. The sinus node is displaced anteriorly and inferiorly, below the crista terminalis 
[19]. In atrial situs inversus, the atria are positioned in a mirror-image fashion, with a left-sided 
sinus node. Heterotaxy syndromes may generally be categorized as either right (asplenia 
syndrome) or left (polysplenia syndrome) atrial isomerism. Patients with right atrial isomerism 
often have bilateral sinus nodes. The governing node may shift from one to the other [20]. In left 
atrial isomerism, sinus nodes are either absent or hypoplastic and displaced posteroinferiorly 
[21]. Congenital sinus node dysfunction is common [21].                                      
AV node and His-Purkinje system                                                                         
The AV conduction system may be displaced if atrial and ventricular septae are malaligned, AV 
arrangements are discordant, or if the heart is univentricular. As a general rule of thumb, if the 
AV conduction system is displaced, it also tends to be more fragile and susceptible to 
degeneration, placing patients at greater risk for AV block.                                             
In atrioventricular canal defects (AVCD), the AV node is displaced inferiorly and posteriorly 
[22]. The His-bundle extends along the lower rim of the ventricular septum. This inferior course 
and hypoplastic left anterior hemifascicle gives rise to the characteristic superior QRS axis. In 
congenitally corrected transposition of the great arteries, or L-TGA, the AV node is displaced 
anteriorly and laterally [23]. An elongated and fragile His-bundle courses across the anterior rim 
of the pulmonary valve. If a ventricular septal defect is present, it continues along its superior 
border [23]. In patients with tricuspid atresia, the AV node is typically found on the floor of the 
right atrium near a small dimple lined with endocardium [24]. The course of the His-Purkinje 
system may vary but is typically further leftward and away from more anterior ventricular septal 
defects [24]. For other forms of univentricular hearts, key determinants of the course of the AV 
conduction system include the direction of ventricular looping and morphology of the dominant 
ventricle [25]. The AV conduction system is often displaced with AV discordance and AVCD. 
In L-looped single left ventricles, two AV nodes may be present [26,27]. The elongated His-
bundle may be susceptible to damage, with complete AV block [26]. With ventricular D-looping 
and a dominant right ventricle, the AV node remains within Koch's triangle [27].            
Arrhythmias In Specific Congenital Heart Disease Lesions                                     
Atrial septal defect (ASD)                                                                                       
Macroreentrant atrial circuits are the most frequent arrhythmias encountered in patients with 
secundum and sinus venosus ASDs. In the absence of surgical repair, typical cavo-tricupsid 
isthmus-dependent atrial flutter is the most common form. In the presence of atriotomy 
incisions, sutures, and/or patches, non-isthmus dependent macroreentrant circuits may occur or 
coexist with typical flutter. Common substrates include macroreentry along the lateral right 
atrial wall and double-loop or figure-of-eight circuits [28,29].                                    
The incidence of atrial arrhythmias increases with age and has been reported in 20% of adults 
[30,31]. Although surgical closure may decrease atrial arrhythmias, it is less effective in older 
patients [30-32]. In 218 adults with isolated ASDs, sustained atrial arrhythmias occurred in 19% 
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prior to surgery: atrial flutter alone in 5%, atrial flutter and fibrillation in 2.8%, and atrial 
fibrillation alone in 11% [30]. Over a post-surgical follow-up of 3.8 years, atrial arrhythmias 
persisted or recurred in 60% of patients diagnosed preoperatively, and 2.3% developed new-
onset arrhythmias. All patients with post-surgical atrial arrhythmias were over 40 years of age at 
time of repair. In a subsequent study that randomized 521 adults over 40 years of age with a 
secundum or sinus venosus ASD to surgical closure versus medical therapy, no difference in 
atrial tachyarrhythmias were noted at a median of 7 years post-operatively [31]. The impact of 
transcatheter ASD closure on atrial arrhythmias is less clear. In one series, all patients with 
persistent arrhythmias remained in atrial fibrillation or flutter after closure [32].                   
 
Ventricular   septal  defect   (VSD)                                                                            
In patients with unoperated VSDs, isolated premature ventricular contractions (PVC), couplets, 
and multiform PVCs are prevalent [33]. Non-sustained or sustained ventricular tachycardia has 
been observed in 6% [33]. A higher mean pulmonary artery pressure is associated with high-
grade ectopy [33]. Nevertheless, in the absence of Eisenmenger syndrome, sudden cardiac death 
is uncommon [34,35]. Late sudden death has been reported in 4% of patients following surgical 
repair [36,37]. Of 296 patients with surgical VSD closure between 1954 and 1960, 20% of 
patients had transpired by 30 years of follow-up [37]. Risk factors for mortality included 
surgical repair after 5 years of age, pulmonary vascular resistance greater than 7 Woods units, 
and complete heart block. In patients who undergo transcatheter VSD closure, AV block is a 
major concern, with an estimated incidence of 3-4% [38].                                                             
Atrioventricular canal defect (AVCD)                                                                                 
In patients with AV canal defects, frequent ventricular ectopy has been described in 30%, while 
complex ventricular arrhythmias are predominantly confined to those with left ventricular 
dysfunction [39]. Persistent complete AV block occurs in 1% to 7% in the immediate post-
operative period and approximately 2% thereafter [39,40]. Prolonged infra-Hisian conduction 
time may be a marker for increased risk of late AV block, even if the PR interval is normal [41]. 
In 18 patients with AVCDs, preoperative electrophysiologic studies revealed sinus node 
dysfunction in 1, supra-Hisian first degree AV block in 5, and intraatrial conduction delay in the 
majority [36]. Atrial fibrillation or flutter has been noted in 5% of patients after surgical repair 
[39,42].
Importantly, since the AV node is displaced just anterior to the mouth of the coronary sinus, 
interventional electrophysiologists should be cautious when ablating in the right inferior 
paraseptal region. For patients with cavo-tricuspid isthmus-dependent macroreentry, lateral 
ablation lines are generally preferred to prevent AV block. With dual AV node physiology, the 
slow pathway has been located superior to the His bundle, with the fast pathway inferior to the 
displaced AV node, as shown in Figure 1 [43].
Left ventricular outflow tract obstruction                                                                   
In patients with left ventricular outflow tract obstruction, ventricular arrhythmias have been 
related to severity of obstruction, increased wall stress, and left ventricular hypertrophy [5,44-
46]. In a series of adults with unoperated aortic stenosis, 34% had high grade ventricular ectopy 
on Holter monitoring, compared to 6% of controls [44]. Correlations with lower left ventricular 
ejection fraction and higher wall stress were later demonstrated [45,46]. Unfortunately, the risk 
of sudden death appears to persist despite surgical repair, warranting lifelong monitoring. 
Indeed, in a population-based study of sudden death after surgery for congenital heart disease, 
patients with aortic stenosis constituted the highest risk subgroup, with an incidence of 3% at 10 
years and 20% at 30 years [6]. Aortic coarctation was also among the high risk lesions [6].
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Figure 1.  Cryomapping and cryoablation combined with 3D electroanatomic mapping in a patient with a partial 
AVCD. Three-dimensional electroanatomic maps of retrograde atrial activation during AV nodal reentrant 
tachycardia in left anterior oblique (Panel A) and left lateral (Panel B) views.  The blue decapolar catheter is 
positioned in the coronary sinus and red quadripolar catheter in the right ventricle.  Green circles indicate sites 
where His-bundle electrograms were recorded.  Local activation times are color-coded, with the site of earliest atrial 
activation in white, inferior to the infero-posteriorly displaced His-bundle.  The yellow circles represent the site of 
successful cryomapping and cryoablation of the slow pathway, superior to the His bundle.  RAA denotes right atrial 
appendage; CSO, coronary sinus ostium. Reproduced from Khairy P. et al. Partial atrioventricular canal defect with 
inverted   atrioventricular   nodal   input   into   an   inferiorly   displaced   atrioventricular   node.   Heart   Rhythm 
2007;4(3):355-8.43. Copyright (2007), with  permission from Elsevier.
Congenitally corrected transposition of the great arteries (L-TGA)                             
Patients with L-TGA have notoriously fragile AV conduction systems.  In 107 patients with L-
TGA and mean age of 22 years, complete AV block occurred in 22% [47]. Risk of AV block 
was estimated to be 2% per year, irrespective of associated anomalies. Electrophysiological 
studies suggest that AV block occurs above or within the His bundle [48,49]. These studies are 
consistent with clinical and pathological observations. A stable narrow QRS escape rhythm 
often accompanies complete AV block [47] and fibrosis of the His bundle is observed 
histologically [49,50]. Since the AV node and His bundle are highly sensitive to catheter or 
surgical trauma, manipulation near these areas should be exercised with caution. Altered 
hemodynamics, such as the volume loading conditions of pregnancy, may place patients at 
higher risk of developing AV block. Complete AV block follows surgical repair of an associated 
VSD in over 25% [47,51].                                                                                       
Ebstein's   anomaly                                                                
In Ebstein's anomaly, the atrialized portion  of  the  right  ventricle  is  morphologically  and 
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electrically right ventricle but functionally right atrium [52]. Mechanical stimulation of the 
atrialized right ventricle may induce ventricular arrhythmias. Otherwise, spontaneous ventricular 
tachycardia is uncommon in the absence of associated malformations, such as aortic coarctation 
or left ventricular outflow tract obstruction [53].                                                                       
Right-sided accessory pathways, classically associated with Ebstein's anomaly, have been 
reported in 25% and may be multiple [52,54,55].  In addition to AV reciprocating tachycardia, 
ectopic atrial tachycardia and atrial fibrillation or flutter can occur. Tachyarrhythmias may be 
poorly tolerated in patients with severe Ebstein's malformation and/or an associated ASDs that 
shunt right-to-left during tachycardia [5]. High risk or multiple pathways may support rapid 
conduction during atrial fibrillation or flutter [55]. Mapping and ablation can be challenging as 
signals in the atrialized portion of the right ventricle may be complex and the true AV groove, 
along which accessory pathways are targeted, may not be readily apparent. To identify the AV 
groove, coronary angiography may be performed or a thin multielectrode catheter may be 
inserted in the right coronary artery [56]. Of 65 patients with Ebstein's anomaly and accessory 
pathways, short-term ablation success rates ranged from 75% to 89%, depending on pathway 
location, with late recurrences in up to 32% [57].                                                       
Univentricular hearts with Fontan palliation                                                                     
The Fontan procedure has undergone multiple modifications to become the treatment of choice 
for various forms of single ventricle physiology [25]. Sudden cardiac death of presumed 
arrhythmic etiology is a major cause of late mortality [58]. Atrial arrhythmias are a challenge to 
manage, often incur substantial morbidity, and may be poorly tolerated hemodynamically. 
Although   some   respond   favorably   to   pharmacological   therapy   [10]   results   are   often 
disappointing.
In general, the incidence of atrial tachyarrhythmias appears lower in patients with total cavo-
pulmonary connections in comparison to classic right atrium to pulmonary artery connections. 
Studies comparing the relative incidence of atrial tachyarrhythmias in patients with lateral tunnel 
versus extracardiac conduits are ongoing. Overall, the most common arrhythmia is atrial 
macroreentry [59]. Although atrial fibrillation may occur, it is surprisingly less common than 
one   would   anticipate,   especially   considering   the   often   extremely   dilated   right   atrium. 
Tachycardia circuits may be complex and/or multiple [28,60,61]. Single circuits that are quite 
amenable to catheter ablation may occasionally be encountered (Figure 2). Overall acute 
success rates exceed 80% [62-64], although recurrences or new onset arrhythmias remain 
problematic, in the order of 30% to 45% within the first year [62,65].
Patients with failing Fontans and refractory atrial arrhythmias should be considered for surgical 
conversion to a total cavopulmonary connection with concomitant arrhythmia surgery. This 
typically includes debulking the right atrium, removing thrombus, excising right atrial scar 
tissue, epicardial pacemaker implantation, a modified right atrial Maze procedure and, in 
patients with prior documented atrial fibrillation, a left-sided Maze procedure as well [66]. Case 
series with short-term follow-up report promising results, with arrhythmia recurrence rates of 
13% to 30% [66-68]. Although the incidence of atrial tachyarrhythmias may be lower, 
extracardiac Fontans substantially complicate transvenous access to arrhythmia circuits, as 
exemplified by Figure 3 [69]. 
Tetralogy of Fallot                                                                                                 
The frequency and nature of arrhythmias encountered in tetralogy of Fallot are related, in part, to 
the type of surgical correction. Repairs were initially performed by means o f  a  ventricular 
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incision. This approach was largely abandoned in favor of transatrial/transpulmonary access to 
reduce risk for potentially fatal ventricular tachyarrhythmias [70]. The most common atrial 
circuit is typical clockwise or counterclockwise atrial flutter utilizing the sub-Eustachian isthmus 
between the tricuspid valve annulus and inferior vena cava, even if the P-wave morphology is 
not characteristic for these arrhythmias [71]. Other circuits often involve the lateral wall and 
may   be  multiple,   often   with  a  double-loop   type   of  reentry.   Non-automatic   focal  atrial 
tachycarrhythmias most commonly arise adjacent to suture points, with radial spread of 
activation. A practical approach to catheter ablation in tetralogy of Fallot has been previously 
described [71].
Figure 2. Electroanatomic mapping in a right atrium to pulmonary artery Fontan. An electroanatomic map (left) 
and imported CMR image (right) are shown in a patient with a classic modified Fontan and recalcitrant atrial 
tachyarrhythmias.  The grey regions denote areas of dense scar.  Local activation times are color-coded, from white 
to red, orange, yellow, green, light blue, dark blue, and purple.  Note the narrow channel of tissue between two 
dense scars.   The arrhythmia circuit propagated counterclockwise around the upper scar and was successfully 
interrupted by ablating this narrow isthmus. Reproduced from Khairy P. EP challenges in adult congenital heart 
disease Heart Rhythm 2008;5(10):1464-72. Copyright (2008), with  permission from Elsevier.
Sudden cardiac death is the most common cause of mortality late after repair [72,73]. 
Monomorphic ventricular tachycardia occurs in approximately 10% of patients by 20 years of 
follow-up, an example of which is depicted in Figure 4 [71]. Nearly all forms are critically 
dependent on at least one of four discrete narrow channels, or isthmuses, portrayed in Figure 5 
[71,74]. Considerable efforts have been directed towards identifying risk factors for ventricular 
tachycardia and sudden death. In the largest cohort study with a mean follow-up >20 years, non-
invasive risk factors were a QRS interval ≥180 ms, an annual increase in QRS duration, older 
age at repair, and presence of a right ventricular outflow tract patch [75]. Patients with 
ventricular   tachycardia   or   sudden   cardiac   death   were   more   likely   to   have   increased 
cardiothoracic ratios, at least moderate pulmonary and tricuspid regurgitation, and peripheral 
pulmonary stenosis. A higher QT dispersion was also noted, believed to reflect increased 
heterogeneity in myocardial repolarization. Other reported risk factors include frequent ectopic 
beats [76] increased right ventricular systolic pressures [77-79] complete heart block [77,80] and 
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increased JT dispersion [81,82]. In patients deemed at moderate risk, further risk stratification 
by means of programmed ventricular stimulation may be helpful [83-85]. Event-free survival 
rates in non-inducible and inducible patients are shown in Figure 6 [83].
Figure 3. Catheter ablation in an extracardiac Fontan via a direct atriotomy approach. A patient with hypoplastic 
left heart syndrome and Ebstein’s malformation of the right-sided   AV valve had poorly tolerated incessant 
orthodromic AV reciprocating tachycardia postoperatively after an extracardiac Fontan with surgical accessory 
pathway ligation.  In Panel A, an anteroposterior view is shown at the site of successful ablation, portraying the 
position of the radiofrequency ablation catheter (black arrow).  The sternum is splayed open by means of thoracic 
retractors.  Epicardial bipolar atrial and ventricular pacing leads are seen.  Shown in Panel B are recordings from 
surface ECG leads II, aVL, and aVF; epicardial high right atrium (HRA); distal (MAP d) and proximal (MAP p) 
electrode pairs of the radiofrequency ablation catheter; and epicardial ventricle (RVA).   Orthodromic AV 
reciprocating tachycardia is seen with the mapping catheter positioned at the site of successful ablation. Reproduced 
from Khairy P et al. Transcatheter ablation via a sternotomy approach as a hybrid procedure in a univentricular 
heart. PACE 2008;31(5):639-40, with permission from Wiley-Blackwell.
Implantable cardioverter-defibrillators (ICD) are increasingly utilized  in the primary and 
secondary prevention of sudden death in patients with tetralogy of Fallot, with patients 
experiencing relatively high rates of appropriate shocks [86]. For patients with primary 
prevention   indications,   a   risk   score   was   derived   from   surgical,   hemodynamic, 
electrocardiographic, and electrophysiological factors (Table 1) [86]. As depicted in Figure 7, 
patients with <3 points (low risk) experienced no appropriate shocks. In patients with 3-5 points 
(intermediate risk) and >5 points (high risk), appropriate shocks were received by 3.8% and 
17.5% of patients per year, respectively [86].                                                                     
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Figure 4. Voltage and pace mapping of ventricular tachycardia in tetralogy of Fallot. In Panel A, a color-coded 
voltage map of the right ventricle in sinus rhythm is shown in a patient with tetralogy of Fallot and ventricular 
tachycardia.  Values below 0.5 mV are depicted in grey and above 1.5 mV in purple.  The presumed ventriculotomy 
incision and ventricular septal defect patch are indicated by the white arrows.  In areas of low voltage, unipolar 
pacing at 10 mAmp/2 ms was performed.  Unexcitable tissue was marked by blue spheres.  Linear ablation (white 
circles at the double red asterisk) was performed connecting two unexcitable areas, i.e. pulmonary annulus and 
ventricular septal defect patch.  TV denotes tricuspid valve; RVA, right ventricular apex; RVOT, right ventricular 
outflow tract.  This site was selected for ablation following pace mapping of the septal RVOT, shown in Panel B.  
Bouts of non-sustained ventricular tachycardia were inducible, corresponding to documented sustained events.  Left 
and right hand panels capture non-sustained ventricular tachycardia and successful 12-lead pace mapping, 
respectively.  In Panel C, block was verified by pacing from a decapolar catheter septal to the ablation line and 
mapping local activation.  Local activation times are color-coded from white to red, orange, yellow, green, light 
blue, dark blue, and purple.  Early activation along the mid-portion of the RVOT adjacent to the ablation line 
suggests a conduction gap.  Additional ablation was performed along the mid-portion of the line, until bidirectional 
block was achieved. Reproduced from Khairy P, Stevenson WG.  Catheter ablation in tetralogy of Fallot. Heart 
Rhythm 2009;6(7):1069-74.71. Copyright (2009), with  permission from Elsevier.
D-transposition of the great arteries (D-TGA)                                                                       
Although arterial switch surgery has supplanted atrial redirection as the procedure of choice for 
D-TGA, most adults with D-TGA have had intraatrial baffle repairs of the Mustard or Senning 
variety. Sinus node dysfunction is highly prevalent with increasing age, with loss of sinus 
rhythm in 60% at 20 years [87]. In a meta-analysis comparing outcomes in 885 patients from 7 
studies, sinus node dysfunction was more common in patients with Mustard procedures [88]. 
Atrial tachyarrhythmias have been reported in 24% of patients at 20 years [87] with similar rates 
in patients with Mustard and Senning baflles [88]. Sudden death is the leading cause of late 
mortality   after   intraatrial   baffle   surgery   [6,87,89,90].   Recent   reports   suggest   that   atrial 
tachyarrhythmias are an important contributor to sudden death [91]. Contributing factors may 
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include longer cycle lengths than typical atrial flutter (favoring 1:1 conduction), impaired AV 
transport with failure to augment right ventricular filling rates during tachycardia [92], systemic 
right ventricular dysfunction [93] and subendocarial ischemia resulting from a right coronary 
circulation irrigating a systemic ventricle [94]. As exemplified by Figure 8, catheter ablation of 
atrial arrhythmias frequently requires access to the pulmonary venous atrium and is often 
successful [95].
Figure 5. Potential critical isthmuses for ventricular tachycardia in surgically repaired tetralogy of Fallot. Potential 
arrhythmia circuits along the right ventricular free wall (Panel A) and septum (Panel B) are indicated by yellow 
arrows.  Small grey circles schematically represent four critical isthmuses for ventricular tachycardia that may be 
transected by catheter ablation. Reproduced from Khairy P, Stevenson WG.  Catheter ablation in tetralogy of Fallot. 
Heart Rhythm 2009;6(7):1069-74.71. Copyright (2009), with  permission from Elsevier.
Figure 6. Value of programmed ventricular stimulation in tetralogy of Fallot. Actuarial freedom from ventricular 
tachycardia (VT) and sudden cardiac death is depicted in patients with no inducible VT, inducible monomorphic 
VT, and inducible polymorphic VT at 1, 5, 10, and 15 years following programmed ventricular stimulation. 
Adapted with permission from Khairy P et al. Value of programmed ventricular stimulation after tetralogy of fallot 
repair: a multicenter study. Circulation 2004;109(16):1994-2000. 
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Table 1.  Risk score for appropriate ICD shocks in patients with tetralogy of Fallot and primary prevention 
indications 
Figure 7. Freedom from appropriate ICD shocks in primary prevention patients with tetralogy of Fallot according 
to their risk category. In patients with primary prevention indications, Kaplan-Meier survival curves for freedom 
from first appropriate ICD shock are plotted and compared according to risk score classification.   Risk score, 
corresponding risk category, number of patients, and annualized rate of appropriate shocks are summarized below. 
Reproduced with permission from Khairy P et al. Circulation 2008;117(3):363-70.
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Figure 8.  Ablation of the cavotricuspid isthmus in D-TGA with Mustard baffle. Panel A depicts an electroanatomic 
map of systemic and pulmonary venous atria.  Local activation times are color-coded, from white to red, orange, 
yellow, green, light blue, dark blue, and purple.  A circuit rotates clockwise around the tricuspid valve (TV).  The 
anatomical relationship between systemic (blue) and pulmonary (purple) venous atria is demonstrated in left 
anterior oblique (Panel B) and posterior (Panel C) views.  Blue circles mark ablation sites and the yellow circle the 
site of successful arrhythmia termination.   Blue and red arrows indicate ablation lesions within systemic and 
pulmonary venous portions of the cavotricuspid isthmus, respectively. Reproduced from Khairy P, Van Hare G.  
Catheter   ablation   in   transposition   of   the   great   arteries   with   Mustard   or   Senning   baffles.   Heart   Rhythm 
2009;6(2):283-9. Copyright (2009), with  permission from Elsevier.
Studies are beginning to address the role of ICDs [91] and cardiac resynchronization therapy for 
failing systemic right ventricles [16,96]. Unfortunately, risk stratification for sudden death 
remains ineffective. In a retrospective multicenter case-control study, risk factors were limited to 
the presence of arrhythmia or heart failure symptoms and history of documented atrial fibrillation 
or flutter [97]. The electrocardiogram, chest x-ray, and Holter findings were not predictive of 
sudden death, and medical therapy and pacemakers were not found to be protective. Moreover, in 
a multicenter cohort study, very few appropriate ICD shocks were received in patients with 
primary prevention indications [91]. The presence or degree of right ventricular dysfunction was 
not associated with appropriate shocks. Encouragingly, beta-blocker therapy appeared protective.
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Summary
Patients   with   congenital   heart   disease   represent   a   heterogeneous   population   with   varied 
arrhythmic   diagnoses   and   issues.   The   last   decade   has   witnessed   major   advances   in   our 
understanding of arrhythmia mechanisms and therapeutic options. Sudden cardiac death of 
presumed arrhythmic etiology is the leading cause of mortality, particularly in patients with left-
sided obstructive lesions, D-TGA and intraatrial baffles, tetralogy of Fallot, and severe systemic 
ventricular dysfunction. Sinus node dysfunction is common in left atrial isomerism and with 
Mustard, Senning, Glenn, or Fontan surgery. Complete AV block frequently occurs in patients 
with L-looped ventricles, left atrial isomerism, and AVCD. Atriotomy incisions, sutures, baffles, 
and conduits may predispose to the development of scar-based macroreentrant atrial circuits, as 
commonly encountered in surgically repaired ASD, Mustard and Senning baffles, tetralogy of 
Fallot, and Fontan palliation.                                                              
ICDs and cardiac resynchronization therapy are increasingly utilized in patients with congenital 
heart disease. Unlike standard indications for patients without congenital heart disease, evidence 
supporting this technology is limited but growing. Guidelines have begun incorporating issues 
relevant to this patient population and targeted training programs are now offered. A thorough 
understanding of conduction system variants, arrhythmia mechanisms, underlying anatomy, and 
physiology is important to safely and effectively manage arrhythmias in this unique and diverse 
patient   population.                                                                        
References
1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 
2002;39:1890-1900.
2. Khairy P. EP challenges in adult congenital heart disease. Heart Rhythm. 2008;5:1464-1472.
3. Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation. 
2007;115:534-545.
4. Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thilen U, Kaemmerer H, Moons 
P, Meijboom F, Popelova J, Laforest V, Hirsch R, Daliento L, Thaulow E, Mulder B. The 
spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-
up period. Eur Heart J. 2005;26:2325-2333.                                                                     
5. Khairy P, Dore A, Talajic M, Dubuc M, Poirier N, Roy D, Mercier LA. Arrhythmias in adult 
congenital heart disease. Expert Rev Cardiovasc Ther. 2006;4:83-95.                               
6. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of 
risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll 
Cardiol.   1998;32:245-251.                                                                        
7. Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with 
congenital heart disease. Am.J.Cardiol. 2000;86:1111-1116.                                    
8. Kanter RJ, Garson A, Jr. Atrial arrhythmias during chronic follow-up of surgery for complex 
congenital heart disease. Pacing Clin.Electrophysiol. 1997;20:502-511.                                        
9. Rekawek J, Kansy A, Miszczak-Knecht M, Manowska M, Bieganowska K, Brzezinska-Paszke 
M, Szymaniak E, Turska-Kmiec A, Maruszewski P, Burczynski P, Kawalec W. Risk factors for 
cardiac arrhythmias in children with congenital heart disease after surgical intervention in the 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 9 (6): 299-317 (2009)Paul Khairy, Seshadri Balaji, “Cardiac Arrhythmias In Congenital Heart Diseases”         312
early postoperative period. J Thorac Cardiovasc Surg. 2007;133:900-904.                              
10. Wells R, Khairy P, Harris L, Anderson CC, Balaji S. Dofetilide for Atrial Arrhythmias in 
Congenital Heart Disease: A Multicenter Study. Pacing Clin Electrophysiol. 2009;[Epub ahead of 
print].
11. Hoyer AW, Balaji S. The safety and efficacy of ibutilide in children and in patients with 
congenital heart disease. Pacing Clin Electrophysiol. 2007;30:1003-1008.                            
12. Thorne SA, Barnes I, Cullinan P, Somerville J. Amiodarone-associated thyroid dysfunction: 
risk factors in adults with congenital heart disease. Circulation. 1999;100:149-154.                    
13. Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S, Dubin AM, Rhee EK, 
Ro PS, Thogersen AM, Cecchin F, Triedman JK, Walsh EP, Berul CI. A multicenter experience 
with novel implantable cardioverter defibrillator configurations in the pediatric and congenital 
heart disease population. J Cardiovasc Electrophysiol. 2006;17:41-46.                         
14. Batra AS, Balaji S. Pacing in adults with congenital heart disease. Expert Rev Cardiovasc 
Ther.   2006;4:663-670.                                                                            
15. Khairy P, Landzberg MJ, Gatzoulis MA, Mercier LA, Fernandes SM, Cote JM, Lavoie JP, 
Fournier A, Guerra PG, Frogoudaki A, Walsh EP, Dore A. Transvenous pacing leads and 
systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation. 
2006;113:2391-2397.
16. Khairy P. Defibrillators and cardiac resynchronisation therapy in congenital heart disease. Exp 
Rev Med Devices. 2008;5:267-271.                                                        
17. Stephenson EA, Casavant D, Tuzi J, Alexander ME, Law I, Serwer G, Strieper M, Walsh EP, 
Berul CI. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in 
patients with congenital heart disease. Am J Cardiol. 2003;92:871-876.                              
18. Anjos RT, Ho SY, Anderson RH. Surgical implications of juxtaposition of the atrial 
appendages. A review of forty-nine autopsied hearts. J Thorac Cardiovasc Surg. 1990;99:897-904.
19. Ho SY, Monro JL, Anderson RH. Disposition of the sinus node in left-sided juxtaposition of 
the atrial appendages. Br Heart J. 1979;41:129-132.                                                               
20. Khairy P, Marelli AJ. Clinical use of electrocardiography in adults with congenital heart 
disease. Circulation. 2007;116:2734-2746.                                                                   
21. Momma K, Takao A, Shibata T. Characteristics and natural history of abnormal atrial rhythms 
in left isomerism. Am.J.Cardiol. 1990;65:231-236.                                                             
22. Anderson RH, Ho SY. The morphology of the specialized atrioventricular junctional area: the 
evolution of understanding. Pacing Clin.Electrophysiol. 2002;25:957-966.                          
23. Anderson RH, Becker AE, Arnold R, Wilkinson JL. The conducting tissues in congenitally 
corrected transposition. Circulation. 1974;50:911-923.                                                             
24. Bharati S, Lev M. The conduction system in tricuspid atresia with and without regular (d-) 
transposition. Circulation. 1977;56:423-429.                                                                     
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 9 (6): 299-317 (2009)Paul Khairy, Seshadri Balaji, “Cardiac Arrhythmias In Congenital Heart Diseases”         313
25. Khairy P, Poirier N, Mercier LA. Univentricular heart. Circulation. 2007;115:800-812.       
26. Bharati S, Lev M. The course of the conduction system in single ventricle with inverted (L-) 
loop and inverted (L-) transposition. Circulation. 1975;51:723-730.                                       
27. Wilkinson JL, Dickinson D, Smith A, Anderson RH. Conducting tissues in univentricular 
heart   of   right   ventricular   type   with   double   or   common   inlet.   J.Thorac.Cardiovasc.Surg. 
1979;77:691-698.
28. Delacretaz E, Ganz LI, Soejima K, Friedman PL, Walsh EP, Triedman JK, Sloss LJ, 
Landzberg MJ, Stevenson WG. Multi atrial maco-re-entry circuits in adults with repaired 
congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic 
mapping. J Am Coll Cardiol. 2001;37:1665-1676.                                                         
29. Shah D, Jais P, Takahashi A, Hocini M, Peng JT, Clementy J, Haissaguerre M. Dual-loop 
intra-atrial reentry in humans. Circulation. 2000;101:631-639.                                                 
30. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical 
closure of atrial septal defects in adults. N.Engl.J.Med. 1999;340:839-846.                             
31. Attie F, Rosas M, Granados N, Zabal C, Buendia A, Calderon J. Surgical treatment for 
secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J Am Coll 
Cardiol.   2001;38:2035-2042.                                                                    
32. Silversides CK, Siu SC, McLaughlin PR, Haberer KL, Webb GD, Benson L, Harris L. 
Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients. 
Heart.   2004;90:1194-1198.                                                                          
33. Liberman L, Kaufman S, Alfayyadh M, Hordof AJ, Apfel HD. Noninvasive prediction of 
pulmonary artery pressure in patients with isolated ventricular septal defect. Pediatr.Cardiol. 
2000;21:197-201.
34. Cohle SD, Balraj E, Bell M. Sudden death due to ventricular septal defect. Pediatr Dev Pathol. 
1999;2:327-332.
35. Sarubbi B, Gerlis LM, Ho SY, Somerville J. Sudden death in an adult with a small ventricular 
septal defect and an aneurysmal membranous septum. Cardiol Young. 1999;9:99-103.             
36. Fournier A, Young ML, Garcia OL, Tamer DF, Wolff GS. Electrophysiologic cardiac function 
before and after surgery in children with atrioventricular canal. Am J Cardiol. 1986;57:1137-1141.
37. Moller JH, Patton C, Varco RL, Lillehei CW. Late results (30 to 35 years) after operative 
closure of isolated ventricular septal defect from 1954 to 1960. Am J Cardiol. 1991;68:1491-1497.
38. Zhou T, Shen XQ, Zhou SH, Fang ZF, Hu XQ, Zhao YS, Qi SS, Li J, Lv XL. Complications 
associated with transcatheter closure of perimembranous ventricular septal defects. Catheter 
Cardiovasc   Interv.   2008;71:559-563.                                                                      
39. Daliento L, Rizzoli G, Marchiori MC, Buja G, Milanesi O, Valente S, Stellin G, Mazzucco A. 
Electrical instability in patients undergoing surgery for atrioventricular septal defect. Int J Cardiol. 
1991;30:15-21.
40. McGrath LB, Gonzalez-Lavin L. Actuarial survival, freedom from reoperation,  and other 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 9 (6): 299-317 (2009)Paul Khairy, Seshadri Balaji, “Cardiac Arrhythmias In Congenital Heart Diseases”         314
events after repair of atrioventricular septal defects. J Thorac Cardiovasc Surg. 1987;94:582-590.  
41.  Jacobsen   JR,  Gillette  PC,  Corbett  BN,  Rabinovitch  M, McNamara  DG.  Intracardiac 
electrography in endocardial cushion defects. Circulation. 1976;54:599-603.                     
42. Vetter VL, Horowitz LN. Electrophysiologic residua and sequelae of surgery for congenital 
heart   defects.   Am   J   Cardiol.   1982;50:588-604.                                                
43. Khairy P, Mercier LA, Dore A, Dubuc M. Partial atrioventricular canal defect with inverted 
atrioventricular nodal input into an inferiorly displaced atrioventricular node. Heart Rhythm. 
2007;4:355-358.
44. Klein RC. Ventricular arrhythmias in aortic valve disease: analysis of 102 patients. Am J 
Cardiol.   1984;53:1079-1083.                                                            
45. von Olshausen K, Schwarz F, Apfelbach J, Rohrig N, Kramer B, Kubler W. Determinants of 
the incidence and severity of ventricular arrhythmias in aortic valve disease. Am J Cardiol. 
1983;51:1103-1109.
46. Santinga JT, Kirsh MM, Brady TJ, Thrall J, Pitt B. Left ventricular function in patients with 
ventricular arrhythmias and aortic valve disease. Ann Thorac Surg. 1983;35:152-155.         
47. Huhta JC, Maloney JD, Ritter DG, Ilstrup DM, Feldt RH. Complete atrioventricular block in 
patients with atrioventricular discordance. Circulation. 1983;67:1374-1377.                    
48. Daliento L, Corrado D, Buja G, John N, Nava A, Thiene G. Rhythm and conduction 
disturbances in isolated, congenitally corrected transposition of the great arteries. Am J Cardiol. 
1986;58:314-318.
49. Gillette PC, Busch U, Mullins CE, McNamara DG. Electrophysiologic studies in patients with 
ventricular inversion and "corrected transposition". Circulation. 1979;60:939-945.                    
50. Foster JR, Damato AN, Kline LE, Akhtar M, Ruskin JN. Congenitally corrected transposition 
of the great vessels: localization of the site of complete atrioventricular block using his bundle 
electrograms.  Am  J  Cardiol.  1976;38:383-387.                                                          
51. McGrath LB, Kirklin JW, Blackstone EH, Pacifico AD, Kirklin JK, Bargeron LM, Jr. Death 
and   other   events   after   cardiac   repair   in   discordant   atrioventricular   connection.   J   Thorac 
Cardiovasc   Surg.   1985;90:711-728.                                                                
52. Ho SY, Goltz D, McCarthy K, Cook AC, Connell MG, Smith A, Anderson RH. The 
atrioventricular junctions in Ebstein malformation. Heart. 2000;83:444-449.                               
53.  Smith WM, Gallagher JJ, Kerr CR, Sealy WC, Kasell JH, Benson DW, Jr., Reiter MJ, Sterba 
R, Grant AO. The electrophysiologic basis and management of symptomatic recurrent tachycardia 
in patients with Ebstein's anomaly of the tricuspid valve. Am J Cardiol. 1982;49:1223-1234.     
54.   Hebe J. Ebstein's anomaly in adults. Arrhythmias: diagnosis and therapeutic approach. 
Thorac.Cardiovasc.Surg. 2000;48:214-219.                                                                       
55.  Attie F, Rosas M, Rijlaarsdam M, Buendia A, Zabal C, Kuri J, Granados N. The adult patient 
with Ebstein anomaly. Outcome in 72 unoperated patients. Medicine (Baltimore). 2000;79:27-36.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 9 (6): 299-317 (2009)Paul Khairy, Seshadri Balaji, “Cardiac Arrhythmias In Congenital Heart Diseases”         315
56. Shah MJ, Jones TK, Cecchin F. Improved localization of right-sided accessory pathways with 
microcatheter-assisted right coronary artery mapping in children. J Cardiovasc Electrophysiol. 
2004;15:1238-1243.
57.  Reich JD, Auld D, Hulse E, Sullivan K, Campbell R. The Pediatric Radiofrequency Ablation 
Registry's   experience   with   Ebstein's   anomaly.   Pediatric   Electrophysiology   Society. 
J.Cardiovasc.Electrophysiol.   1998;9:1370-1377.                                                            
58.  Khairy P, Fernandes SM, Mayer JE, Jr., Triedman JK, Walsh EP, Lock JE, Landzberg MJ. 
Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. 
Circulation.   2008;117:85-92.                                                                      
59.   Gatzoulis   MA,   Munk   MD,   Williams   WG,   Webb   GD.   Definitive   palliation   with 
cavopulmonary or aortopulmonary shunts for adults with single ventricle physiology. Heart. 
2000;83:51-57.
60.  Triedman JK, Jenkins KJ, Colan SD, Saul JP, Walsh EP. Intra-atrial reentrant tachycardia 
after palliation of congenital heart disease: characterization of multiple macroreentrant circuits 
using   fluoroscopically   based   three-dimensional   endocardial   mapping.   J   Cardiovasc 
Electrophysiol.   1997;8:259-270.                                                                            
61. Triedman JK, Alexander ME, Berul CI, Bevilacqua LM, Walsh EP. Electroanatomic mapping 
of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial 
reentrant tachycardia. Circulation. 2001;103:2060-2065.                                                     
62.   Kannankeril PJ, Anderson ME, Rottman JN, Wathen MS, Fish FA. Frequency of late 
recurrence of intra-atrial reentry tachycardia after radiofrequency catheter ablation in patients with 
congenital heart disease. Am J Cardiol. 2003;92:879-881.                                                             
63. Triedman JK. Arrhythmias in adults with congenital heart disease. Heart. 2002;87:383-389.  
64. Triedman JK, DeLucca JM, Alexander ME, Berul CI, Cecchin F, Walsh EP. Prospective trial 
of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with 
congenital heart disease. Heart Rhythm. 2005;2:700-705.                                                       
65. Triedman JK, Alexander ME, Love BA, Collins KK, Berul CI, Bevilacqua LM, Walsh EP. 
Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of 
intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 
2002;39:1827-1835.
66. Mavroudis C, Deal BJ, Backer CL. The beneficial effects of total cavopulmonary conversion 
and arrhythmia surgery for the failed Fontan. Semin Thorac Cardiovasc Surg Pediatr Card Surg 
Annu.   2002;5:12-24.                                                                    
67. Setty SP, Finucane K, Skinner JR, Kerr AR. Extracardiac conduit with a limited maze 
procedure for the failing Fontan with atrial tachycardias. Ann Thorac Surg. 2002;74:1992-1997.  
68. Petko M, Myung RJ, Wernovsky G, Cohen MI, Rychik J, Nicolson SC, Gaynor JW, Spray 
TL.   Surgical   reinterventions   following   the   Fontan   procedure.   Eur.J.Cardiothorac.Surg. 
2003;24:255-259.
69. Khairy P, Fournier A, Ruest P, Vobecky SJ. Transcatheter ablation via a sternotomy approach 
as a hybrid procedure in a univentricular heart. Pacing Clin Electrophysiol. 2008;31:639-640.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 9 (6): 299-317 (2009)Paul Khairy, Seshadri Balaji, “Cardiac Arrhythmias In Congenital Heart Diseases”         316
70. Karamlou T, McCrindle BW, Williams WG. Surgery insight: late complications following 
repair of tetralogy of Fallot and related surgical strategies for management. Nat Clin Pract 
Cardiovasc   Med.   2006;3:611-622.                                                                      
71.   Khairy   P,   Stevenson   WG.   Catheter   ablation   in   tetralogy   of   Fallot.   Heart   Rhythm. 
2009;6:1069-1074.
72. Gillette PC, Garson A, Jr. Sudden cardiac death in the pediatric population. Circulation. 
1992;85(1   Suppl):I64-I69.                                                                                      
73. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B. Long-term survival 
in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year 
after surgical repair. J Am Coll Cardiol. 1997;30:1374-1383.                                
74.  Zeppenfeld K, Schalij MJ, Bartelings MM, Tedrow UB, Koplan BA, Soejima K, Stevenson 
WG. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: 
electroanatomic   identification   of   the   critical   right   ventricular   isthmus.   Circulation. 
2007;116:2241-2252.
75. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa 
M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden 
cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975-
981.
76. Harrison DA, Harris L, Siu SC, MacLoghlin CJ, Connelly MS, Webb GD, Downar E, 
McLaughlin PR, Williams WG. Sustained ventricular tachycardia in adult patients late after repair 
of tetralogy of Fallot. J Am Coll Cardiol. 1997;30:1368-1373.                                                 
77. Jonsson H, Ivert T, Brodin LA, Jonasson R. Late sudden deaths after repair of tetralogy of 
Fallot. Electrocardiographic findings associated with survival. Scand J Thorac Cardiovasc Surg. 
1995;29:131-139.
78. Garson A, Nihill MR, McNamara DG, Cooley DA. Status of the adult and adolescent after 
repair of tetralogy of Fallot. Circulation. 1979;59:1232-1240.                                                       
79. Katz NM, Blackstone EH, Kirklin JW, Pacifico AD. Late survival and symptoms after repair 
of tetralogy of Fallot. Circulation. 1982;65:403-410.                                                                     
80. Hokanson JS, Moller JH. Significance of early transient complete heart block as a predictor of 
sudden death late after operative correction of tetralogy of Fallot. Am J Cardiol. 2001;87:1271-
1277.
81. Berul CI, Hill SL, Geggel RL, Hijazi ZM, Marx GR, Rhodes J, Walsh KA, Fulton DR. 
Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot 
children. J Cardiovasc Electrophysiol. 1997;8:1349-1356.                                                                 
82. Vogel M, Sponring J, Cullen S, Deanfield JE, Redington AN. Regional wall motion and 
abnormalities of electrical depolarization and repolarization in patients after surgical repair of 
tetralogy of Fallot. Circulation. 2001;103:1669-1673.                                                               
83. Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marcon F, Alexander ME, 
Walsh EP. Value of programmed ventricular stimulation after tetralogy of fallot repair: a 
multicenter study. Circulation. 2004;109:1994-2000.                                                             
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 9 (6): 299-317 (2009)Paul Khairy, Seshadri Balaji, “Cardiac Arrhythmias In Congenital Heart Diseases”         317
84. Khairy P. Programmed ventricular stimulation for risk stratification in patients with tetralogy 
of Fallot: a Bayesian perspective. Nat Clin Pract Cardiovasc Med. 2007;4:292-293.             
85. Khairy P, Dore A, Poirier N, Marcotte F, Ibrahim R, Mongeon FP, Mercier LA. Risk 
stratification in surgically repaired tetralogy of Fallot. Expert Rev Cardiovasc Ther. 2009;7:755.  
86. Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gatzoulis MA, Fernandes SM, 
Beauchesne L, Therrien J, Chetaille P, Gordon E, Vonder Muhll I, Cecchin F. Implantable 
cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008;117:363-370.                 
87. Gelatt M, Hamilton RM, McCrindle BW, Connelly M, Davis A, Harris L, Gow RM, Williams 
WG, Trusler GA, Freedom RM. Arrhythmia and mortality after the Mustard procedure: a 30-year 
single-center experience. J Am Coll Cardiol. 1997;29:194-201.                                  
88. Khairy P, Landzberg MJ, Lambert J, O'Donnell CP. Long-term outcomes after the atrial 
switch for surgical correction of transposition: a meta-analysis comparing the Mustard and 
Senning procedures. Cardiol Young. 2004;14:284-292.                                                           
89. Gatzoulis MA, Walters J, McLaughlin PR, Merchant N, Webb GD, Liu P. Late arrhythmia in 
adults with the mustard procedure for transposition of great arteries: a surrogate marker for right 
ventricular dysfunction? Heart. 2000;84:409-415.                                                             
90.   Kirjavainen   M,   Happonen   JM,   Louhimo   I.   Late   results   of   Senning   operation. 
J.Thorac.Cardiovasc.Surg. 1999;117:488-495.                                                                   
91. Khairy P, Harris L, Landzberg MJ, Fernandes SM, Barlow A, Mercier LA, Viswanathan S, 
Chetaille P, Gordon E, Dore A, Cecchin F. Sudden death and defibrillators in transposition of the 
great arteries with intra-atrial baflles: a multicenter study. Circulation: Arrhythmia Electrophysiol. 
2008;1:250-257.
92. Derrick GP, Narang I, White PA, Kelleher A, Bush A, Penny DJ, Redington AN. Failure of 
stroke  volume  augmentation  during  exercise  and dobutamine  stress is unrelated  to load-
independent indexes of right ventricular performance after the Mustard operation. Circulation. 
2000;102(19   Suppl   3):III154-159.                                                        
93. Pettersen E, Helle-Valle T, Edvardsen T, Lindberg H, Smith HJ, Smevik B, Smiseth OA, 
Andersen K. Contraction pattern of the systemic right ventricle shift from longitudinal to 
circumferential   shortening   and   absent   global   ventricular   torsion.   J   Am   Coll   Cardiol. 
2007;49:2450-2456.
94. Millane T, Bernard EJ, Jaeggi E, Howman-Giles RB, Uren RF, Cartmill TB, Hawker RE, 
Celermajer DS. Role of ischemia and infarction in late right ventricular dysfunction after atrial 
repair of transposition of the great arteries. J Am Coll Cardiol. 2000;35:1661-1668.           
95. Khairy P, Van Hare GF. Catheter ablation in transposition of the great arteries with Mustard or 
Senning baffles. Heart Rhythm. 2009;6:283-289.                                                      
96.   Khairy   P,   Fournier   A,   Thibault   B,   Dubuc   M,   Therien   J,   Vobecky   SJ.   Cardiac 
resynchronization therapy in congenital heart disease. Int J Cardiol. 2006;109:160-168.            
97.  Kammeraad JA, van Deurzen CH, Sreeram N, Bink-Boelkens MT, Ottenkamp J, Helbing 
WA, Lam J, Sobotka-Plojhar MA, Daniels O, Balaji S. Predictors of sudden cardiac death after 
Mustard   or   Senning   repair   for   transposition   of   the   great   arteries.   J   Am   Coll   Cardiol. 
2004;44:1095-1102.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 9 (6): 299-317 (2009)